## 

## 



## 

## 


## 



## 

## 

## 



## 

## 

## 

## 

## 


## 

|<br>including the following:||
|---|---|
|**Information booklets**||
|A medical Guide for Patients with Myasthenia<br>Gravis|Ocular Myasthenia - a guide for the medical<br>professionals|
|A medical Guide for Patients with LEMS|Myasthenia andpregnancyfactsheet|
|MyastheniaforComplete Beginners|WhoamI? Booklet(myasthenia simplified)|
|Congenital Myasthenia - aguide|Variety offlyerspromotingmyaware services|
|Ocular Myasthenia - a guideforpatients||





## 

## 

## 

## 

## 

|Support|£540,833|
|---|---|
|Research|£366,588|
|**Awareness**|£105,233|
|Fundraising|£9,499|



## 

## 




## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

|**Website performance**|||||
|---|---|---|---|---|
|||**2020/2021**||**2021/2022**|
|Visitors to the website:||157,717||151,229|
|Pages most visited:||•<br>Drugs to avoid<br>•<br>Pyridostigmine information<br>•<br>Coronavirus information||•<br>Drugs to avoid<br>•<br>Extraocular muscles<br>•<br>Pyridostigmine information|
|Averages session length||1.41seconds||1.46 seconds|
|Bounce back rate:||74.09%||72.65%|
|Numberofpages viewed<br>duringeach session||2.02||2.12|





## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

|Notes<br>**INCOME AND ENDOWMENTS FROM**<br>Donationsandlegacies<br>3<br>Othertrading activities<br>4<br>Investment income<br>5<br>Total<br>EXPENDITUREON<br>Raising funds<br>6<br>Charitableactivities<br>7<br>Research<br>Support<br>Awareness<br>Total<br>Netgainsoninvestments<br>NETINCOME/(EXPENDITURE)<br>Transfersbetweenfunds<br>21<br>Netmovementinfunds<br>RECONCILIATIONOFFUNDS<br>Totalfundsbroughtforward<br>TOTAL**FUNDS CARRIED FORWARD**||Unrestricted<br>fund<br>£<br>**635,330**<br>**118,908**<br>**7!832**|Restricted<br>funds<br>£<br>**5,636**<br>**(60,802)**|**2022**<br>Total<br>funds<br>£<br>**640,966**<br>**58,106**<br>**71832**|2021<br>Total<br>funds<br>£<br>675,821<br>306,918<br>10,060<br>992,799<br>10,329<br>326,043<br>635,542<br>80,503<br>1,052,417<br>35,783<br>(23,835)<br>(23,835)<br>2,726,884<br>2,7031049|
|---|---|---|---|---|---|
|||**762,070**<br>**9,499**<br>**75,563**<br>**520,538**<br>**104,441**|**(55,166)**<br>**291,025**<br>**20,295**<br>792|**706,904**<br>**9,499**<br>**366,588**<br>**540,833**<br>**105,233**||
|||**710,041**<br>**18,493**<br>**70,522**<br>**16,715**|**312,112**<br>**(367,278)**<br>**(16,715)**|**1,022,153**<br>**18,493**<br>**(296,756)**||
|||**87,237**<br>**1,640,760**<br>**1!7271997**|**(383,993)**<br>**1,062,289**<br>**6781296**|**(296,756)**<br>**2,703,049**<br>**214061293**||



|Notes<br>FIXED**ASSETS**<br>Intangible assets<br>14<br>Tangible assets<br>15<br>Investments<br>16<br>CURRENTASSETS<br>Stocks<br>17<br>Debtors<br>18<br>Cashatbankandinhand<br>CREDITORS<br>Amountsfallingduewithinoneyear<br>19<br>NETCURRENTASSETS<br>TOTALASSETSLESSCURRENTLIABILITIES<br>CREDITORS<br>Amountsfallingdueaftermorethanoneyear<br>20<br>NETASSETS<br>FUNDS<br>21<br>Unrestricted funds<br>Restricted funds<br>TOTALFUNDS||Unrestricted<br>Restricted<br>fund<br>funds<br>£<br>£<br>7,709<br>**4,030**<br>229,797||**2022**<br>Total<br>funds<br>£<br>7,709<br>**4,030**<br>229,797|2021<br>Total<br>funds<br>£<br>23,477<br>3,661<br>211,304|
|---|---|---|---|---|---|
|||**241,536**<br>**4,364**<br>**577,599**<br>**914,288**<br>**1,178,742**||**241,536**<br>**4,364**<br>**577,599**<br>**2,093,030**|238,442<br>2,138<br>859,595<br>2,040,174|
|||**1,496,251**<br>**1,178,742**<br>(9,790)<br>(200,690)<br>**1,486,461**<br>**978,052**<br>**1,727,997**<br>**978,052**<br>**(299,756)**<br>**1z727,997**<br>**678,296**||**2,674,993**<br>**(210,480)**<br>**2,464,513**<br>2,706,049<br>**(299,756)**<br>**2,4061293**|2,901 ,907<br>(273,400)<br>2,628,507<br>2,866,949<br>(163,900)<br>2,703,049|
|||||**1,727,997**<br>**678,296**|1,640,760<br>1,062,289|
|||||**2,406,293**|2,703,049|






## 

## 

|||2022|2021|
|---|---|---|---|
||Notes|£|£|
|Cashflowsfrom operating activities||||
|Cash generated from operations|1|**48,226**|195,137|
|Net cash provided by operating activities||**48,226**|195,137|
|Cashflowsfrominvesting activities||||
|Purchase of intangible fixed assets|||(14,759)|
|Purchase of tangible fixed assets||**(3,445)**|(2,768)|
|Saleofintangible fixed assets||**243**||
|Interest received||**7,832**|10,060|
|Net cash provided by/(used in) investing activities||**4,630**|(7,467)|
|Changeincash and cash equivalentsin||||
|thereporting period||**52,856**|187,670|
|Cash and cash equivalentsatthe||||
|beginningofthereporting period||**2,040,174**|1,852,504|
|Cash and cash equivalentsatthe endof||||
|thereporting period||**2,093,030**|2,040,174|



## 

|1.|RECONCILIATION OF NET EXPENDITURE TO NET CASH FLOW FROM|OPERATING ACTIVITIES|OPERATING ACTIVITIES|
|---|---|---|---|
|||2022|2021|
|||£|£|
||Net expenditureforthereporting period (as pertheStatementof|||
||FinancialActivities)|**(296,756)**|(23,835)|
||Adjustmentsfor:|||
||Depreciation charges|**18,601**|31,643|
||Gain on investments|**(18,493)**|(35,783)|
||Interest received|**(7,832)**|(10,060)|
||(lncrease)/decrease in stocks|**(2,226)**|1,491|
||Decrease in debtors|**281,996**|3,802|
||Increase in creditors|**72,936**|227,879|
||Net cashprovidedbyoperations|**48,226**|195,137|



|2.<br>**ANALYSIS**OF CHANGESINNET FUNDS<br>At1/4/21<br>£<br>Net cash<br>Cash at bank and in hand<br>**2,040,174**<br>**2,040,174**<br>Total<br>**2,040,174**||Cash flow<br>£<br>**52,856**<br>**52,856**|**At 31/3/22**<br>£<br>**2,093,030**<br>**2,093,030**|
|---|---|---|---|
|||**52,856**|**2,093,030**|





## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

|OTHER TRADING ACTIVITIES||||
|---|---|---|---|
|Affinity programmes<br>Appeals<br>Collections<br>Corporate<br>Grants<br>Lotteries<br>National events<br>Regional events<br>Salesofmerchandise<br>Trusts|2022<br>£<br>**1,890**<br>7,370<br>**468**<br>**7,339**<br>**(53,847)**<br>**4,334**<br>**17,906**<br>**36,813**<br>**4,928**<br>**30,905**<br>**58,106**||2021<br>£<br>623<br>15,978<br>921<br>7,065<br>140,428<br>5,382<br>9,225<br>36,263<br>4,686<br>86,347<br>306,918|
|||||



## 

||**2022**|2021|
|---|---|---|
||£|£|
|Deposit account interest|**908**|3,815|
|Current account interest|**538**|150|
|Dividends on shares and other investments|**6,386**|6,095|
||**7,832**|10,060|
|||=--,|



## 

## 

|**2022**<br>£<br>Donations<br>**95,583**<br>Legacies<br>**490,115**<br>Grants<br>**9,218**<br>InMemoriam<br>**46,050**<br>640,966|2021<br>£<br>83,601<br>519,560<br>29,355<br>43,305<br>675,821|
|---|---|



## 

|Raisingdonationsand legacies|||
|---|---|---|
||**2022**|2021|
||£|£|
|Merchandise|**2,173**|2,976|
|Events|**3,098**|3,357|
|Appeal mailings|**996**|349|
|Lottery|**3,232**|3,647|
||~|~|





## 

## 

## 

|Research<br>Support<br>Awareness||Direct<br>Costs(see<br>note 8)<br>£<br>**347,451**<br>**407,124**<br>**781472**<br>**833,047**|Support<br>costs (see<br>note9)<br>Totals<br>£<br>£<br>**19,137**<br>**366,588**<br>**133,709**<br>**540,833**<br>**26i761**<br>**1051233**<br>**179,607**<br>**1,012,654**|
|---|---|---|---|



## 

|Staffcosts<br>Medical research<br>Medical care<br>Travel and miscellaneous<br>MyNews &membercommunications<br>Meetings and conferences|**2022**<br>2021<br>£<br>£<br>**528,511**<br>580,867<br>**291,025**<br>267,677<br>**1,529**<br>**6,829**<br>5,600<br>**4,098**<br>7,158<br>**11055**<br>1427<br>**833,047**<br>862,729|
|---|---|



## 

|Commitmentsasat1 April 2021<br>Commitments made intheyear<br>Commitments released intheyear<br>Grants paid during theyear<br>Commitmentsasat31 March 2022|**2022**<br>2021<br>£<br>£<br>421,705<br>184,343<br>323,919<br>275,772<br>(32,894)<br>(8,095)<br>(212,284)<br>(30,315)<br>500,446<br>421,705|
|---|---|



## 

|Research<br>Support<br>Awareness<br>Management<br>£<br>**17,568**<br>**123,158**<br>**241623**<br>**165,349**|<br>Governance<br>costs<br>Totals<br>£<br>£<br>**1,569**<br>**19,137**<br>**10,551**<br>**133,709**<br>**21138**<br>**261761**<br>~~**14,258**~~<br>**179,607**|
|---|---|



## 

## 

## 

|Rentalofpremises<br>Utilities and insurance<br>Office equipment<br>Printing, postage and<br>stationery<br>Photocopier costs<br>Support website<br>ITsupport & software<br>HRcosts<br>General expenses<br>Bank charges<br>Amortisationofintangible<br>fixed assets<br>Depreciationoftangible<br>fixed assets<br>Governancecosts<br>Trustees' expenses<br>Auditors' remuneration<br>Legalandprofessional fees<br>**NET INCOME/(EXPENDITURE)**<br>Net income/(expenditure) is stated<br>Auditors' remuneration<br>Depreciation - owned assets<br>Computer software amortisation|Research<br>Support<br>£<br>£<br>**2,613**<br>**17,579**<br>**1,999**<br>**13,451**<br>**3,845**<br>**1,097**<br>**7,383**<br>**143**<br>**961**<br>**2,633**<br>**17,710**<br>**4,982**<br>**34,642**<br>**1,140**<br>**7,663**<br>**751**<br>**5,050**<br>**165**<br>**1,108**<br>**1,707**<br>**11,489**<br>**338**<br>2,277<br>**17,568**<br>**123,158**<br>Research<br>Support<br>£<br>£<br>**26**<br>**172**<br>**800**<br>**5,379**<br>**743**<br>**5,000**<br>~~<br>after charging/(crediting):|Support<br>£<br>**17,579**<br>**13,451**<br>**3,845**<br>**7,383**<br>**961**<br>**17,710**<br>**34,642**<br>**7,663**<br>**5,050**<br>**1,108**<br>**11,489**<br>2,277<br>**123,158**|<br>**2022**<br>2021<br>Total<br>Total<br>Awareness<br>activities<br>activities<br>£<br>£<br>£<br>**3,563**<br>**23,755**<br>**23,760**<br>2,727<br>**18,177**<br>**17,255**<br>**3,845**<br>**2,315**<br>**1,497**<br>9,977<br>**11,680**<br>**195**<br>**1,299**<br>**1,009**<br>**3,590**<br>**23,933**<br>**30,461**<br>7,460<br>**47,084**<br>**38,773**<br>**1,553**<br>**10,356**<br>**5,044**<br>**1,024**<br>**6,825**<br>**1,131**<br>**224**<br>**1,497**<br>**1,573**<br>**2,329**<br>**15,525**<br>**25,363**<br>**461**<br>**31076**<br>**61280**<br>**24,623**<br>**165,349**<br>**164,644**<br>**2022**<br>2021<br>Total<br>Total<br>Awareness<br>activities<br>activities<br>£<br>£<br>£<br>**35**<br>**233**<br>**1,089**<br>**7,268**<br>**7,941**<br>**1,014**<br>**6,757**<br>**6,774**<br>~~~<br>**2022**<br>2021<br>£<br>£<br>**7,268**<br>7,941<br>**3,076**<br>6,280<br>~~|
|---|---|---|---|



## 



## 

## 

|Trustees'expenses|||
|---|---|---|
||2022|2021|
||£|£|
|Trustees' expenses|**233**<br>-||



## 

|2022<br>£<br>Wages and salaries<br>**463,558**<br>Social security costs<br>34,490<br>Other pension costs<br>**30,463**<br>**528,511**|2021<br>£<br>509,640<br>36,906<br>34,321<br>580,867|
|---|---|



|The average monthly numberofemployees during theyearwas|as follows:||
|---|---|---|
||2022|2021|
|Fundraising, support and awareness|**15**|20|
|Managementandoperationsofthecharity|4|4|
||**19**|24|



||||**2022**|2021|
|---|---|---|---|---|
|£60,001|-|£70,000|**1**||



## 

|**13. **<br>**COMPARATIVESFORTHESTATEMENTOFFINANCIAL ACTIVITIES**<br>Unrestricted<br>fund<br>£<br>**INCOMEANDENDOWMENTSFROM**<br>Donations and legacies<br>673,194<br>Othertrading activities<br>125,725<br>Investment income<br>10,060<br>Total<br>808,979<br>**EXPENDITUREON**<br>Raising funds<br>10,329<br>**Charitable activities**<br>Research<br>54,506<br>Support<br>432,395<br>**Awareness**<br>80,503<br>**Total**<br>577,733<br>Netgainson investments<br>35,783<br>**NETINCOME/(EXPENDITURE)**<br>267,029<br>Transfersbetweenfunds<br>73,908<br>Netmovementinfunds<br>340,937<br>RECONCILIATIONOFFUNDS<br>Totalfundsbroughtforward<br>1,299,823<br>**TOTALFUNDSCARRIEDFORWARD**<br>1,640,760|Restricted<br>funds<br>£<br>2,627<br>181,193|Total<br>funds<br>£<br>675,821<br>306,918<br>10,060<br>992,799<br>10,329<br>326,043<br>635,542<br>80,503<br>1,052,417<br>35,783<br>(23,835)<br>(23,835)<br>2,726,884<br>2,703,049|
|---|---|---|
||183,820<br>271,537<br>203,147||
||474,684<br>(290,864)<br>{73,908)||
||(364,772)<br>1,427,061<br>1,062,289||





## 

## 

|INTANGIBLE FIXED ASSETS||
|---|---|
||Computer|
||software|
||£|
|COST||
|At1 April2021|**95,736**|
|Disposals|~)|
|At31March 2022|**95,007**|
|AMORTISATION||
|At1 April2021|**72,259**|
|Charge foryear|**15,525**|
|Eliminated on disposal|~)|
|At31March 2022|**87,298**|
|NETBOOKVALUE||
|At31March 2022|7,709|
||-|
|At31March 2021|~|



## 

||Fixtures|||
|---|---|---|---|
||and|Computer||
||fittings|equipment|Totals|
||£|£|£|
|COST||||
|At1 April 2021|**13,247**|**41,763**|**55,010**|
|Additions||**3,445**|**3,445**|
|At31March 2022|**13,247**|**45,208**|**58,455**|
|DEPRECIATION||||
|At1 April 2021<br>Charge for year|**13,247**.<br>--|**38,102**<br>**3,076**|**51,349**<br>**3,076**|
|At31March 2022|**13,247**|**41,178**|**54,425**|
|NET BOOK VALUE||||
|At31March 2022||~|~|
|At31March 2021||~|~|
|FIXED ASSET INVESTMENTS||||
||||Listed|
||||investments|
||||£|
|MARKET VALUE||||
|At1 April 2021|||**211,304**|
|Revaluations|||**18,493**|
|At31March 2022|||229,797|
|NETBOOKVALUE||||
|At31March 2022|||229,797|
|At31March 2021|||211,304|



## 

## 

## 

|Finished goods<br>**18.**<br>DEBTORS: AMOUNTSFALLINGDUE WITHIN ONEYEAR<br>Other debtors<br>Prepayments and accrued income<br>**19.**<br>**CREDITORS: AMOUNTS FALLING**DUE**WITHINONEYEAR**<br>Other creditors<br>Committed grants<br>Accruals and deferred income<br>20.<br>CREDITORS: AMOUNTS FALLING DUE AFTER MORETHANONE YEAR<br>Committed grants|2022<br>£<br>~<br>2022<br>£<br>**568,640**<br>**8,959**<br>**577,599**||2021<br>£<br>2,138<br>-<br>2021<br>£<br>848,353<br>11,242<br>859,595<br>2021<br>£<br>6,864<br>257,805<br>8,731<br>273,400<br>2021<br>£<br>163,900|
|---|---|---|---|
||**2022**<br>£<br>**1,039**<br>**200,690**<br>**8,751**<br>**210,480**<br>2022<br>£<br>**299,756**|||





## 

## 

|**21.**<br>**MOVEMENT IN FUNDS**<br>Unrestrictedfunds<br>General fund<br>Restrictedfunds<br>Research<br>Support<br>Awareness<br>TOTAL FUNDS||At1/4/21<br>£<br>**1,640,760**<br>**860,312**<br>**198,440**<br>**3,537**<br>**1,062,289**|Net<br>movement<br>infunds<br>£<br>**70,522**<br>**(287,494)**<br>(79,992)<br>**208**<br>**{367,278)**<br>**!296,756)**<br>Transfers<br>between<br>At<br>funds<br>31/3/22<br>£<br>£<br>**16,715**<br>**1,727,997**<br>**572,818**<br>**(16,715)**<br>**101,733**<br>**3,745**<br>**{16,715)**<br>**678,296**<br>**2,406,293**|
|---|---|---|---|
|||**2,703,049**||



## 

|Unrestrictedfunds<br>General fund<br>Restrictedfunds<br>Research<br>Support<br>Awareness<br>TOTAL FUNDS<br>Comparativesformovementinfunds<br>Unrestrictedfunds<br>General fund<br>Restrictedfunds<br>Research<br>Support<br>Awareness<br>TOTALFUNDS||Incoming<br>resources<br>£<br>762,070<br>**3,531**<br>**(59,697)**<br>**1,000**<br>**(55**~~**1**~~**166)**<br>706,904<br>At1/4/20<br>£<br>1,299,823<br>1,204,757<br>220,117<br>2,187<br>1,427,061|Resources<br>expended<br>£<br>**(710,041)**<br>**(291,025)**<br>**(20,295)**<br>(792)<br>**(3121112)**<br>**!1,022,153)**<br>Net<br>movement<br>in funds<br>£<br>267,029<br>(270,537)<br>(21,677)<br>1,350<br>(290,864)|Gains and<br>Movement<br>losses<br>infunds<br>£<br>£<br>**18,493**<br>**70,522**<br>**(287,494)**<br>(79,992)<br>**208**<br>**(3671278)**<br>**18,493**<br>**!296,756)**<br>Transfers<br>between<br>At<br>funds<br>31/3/21<br>£<br>£<br>73,908<br>1,640,760<br>(73,908)<br>860,312<br>198,440<br>3,537<br>(73,908)<br>1,062,289<br>2,703,049|
|---|---|---|---|---|
||||||
|||2,726,884|(23,835)||



## 

|Comparative net movementinfunds, included in the above areasfollows:|ed in the above areasfollows:|ed in the above areasfollows:|ed in the above areasfollows:|||
|---|---|---|---|---|---|
|Incoming<br>Resources<br>resources<br>expended<br>£<br>£<br>Unrestrictedfunds<br>General fund<br>808,979<br>(577,733)<br>Restrictedfunds<br>Research<br>1,000<br>(271,537)<br>Support<br>181,470<br>(203,147)<br>Awareness<br>1,350<br>183,820<br>(474,684)<br>TOTAL FUNDS<br>992,799<br>p ,052,417)<br>A current year 12 months and prior year12months combined position is as follows:<br>Net<br>movement<br>At1/4/20<br>in funds<br>£<br>£<br>Unrestrictedfunds<br>General fund<br>1,299,823<br>337,551<br>Restrictedfunds<br>Research<br>1,204,757<br>(558,031)<br>Support<br>220,117<br>(101 ,669)<br>Awareness<br>2 187<br>1,558<br>1,427,061<br>(658,142)<br>TOTAL FUNDS<br>2,726,884<br>!320,591)<br>Gains and<br>Movement<br>losses<br>in funds<br>£<br>£<br>35,783<br>267,029<br>(270,537)<br>(21,677)<br>1,350<br>(290,864)<br>35,783<br>!23,835)<br>Transfers<br>between<br>At<br>funds<br>31/3/22<br>£<br>£<br>90,623<br>1,727,997<br>(73,908)<br>572,818<br>(16,715)<br>101,733<br>3,745<br>(90,623)<br>678,296<br>2,406,293<br>A current year 12 months and prior year 12 months combinednetmovement in funds, included in the above are<br>as follows:|Incoming<br>Resources<br>resources<br>expended<br>£<br>£<br>808,979<br>(577,733)<br>1,000<br>(271,537)<br>181,470<br>(203,147)<br>1,350|||Gains and<br>losses<br>£<br>35,783|Movement<br>in funds<br>£<br>267,029<br>(270,537)<br>(21,677)<br>1,350|
||183,820<br>(474,684)||||(290,864)|
||992,799<br>p ,052,417)||||!23,835)<br>At<br>31/3/22<br>£<br>1,727,997<br>572,818<br>101,733<br>3,745<br>678,296|
|||2,726,884|!320,591)||2,406,293|



|<br>as follows:||
|---|---|
|Unrestrictedfunds<br>General fund<br>Restrictedfunds<br>Research<br>Support<br>Awareness<br>TOTAL FUNDS|Incoming<br>Resources<br>Gains and<br>Movement<br>resources<br>expended<br>losses<br>in funds<br>£<br>£<br>£<br>£<br>1,571,049<br>(1,287,774)<br>54,276<br>337,551<br>4,531<br>(562,562)<br>(558,031)<br>121,773<br>(223,442)<br>(101 ,669)<br>2,350<br>(792)<br>1,558|
||128,654<br>(786,796)<br>(658,142)|
||1,699,703<br>!2,074,570)<br>54,276<br>!320,591)|





## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

||2022|2021|
|---|---|---|
||£|£|
|INCOME AND ENDOWMENTS|||
|Donations and legacies|||
|Donations|**95,583**|83,601|
|Legacies|**490,115**|519,560|
|Grants|**9,218**|29,355|
|In Memoriam|**46,050**|43,305|
||640,966|675,821|
|Othertradingactivities|||
|Affinity programmes|**1,890**|623|
|Appeals|**7,370**|15,978|
|Collections|**468**|921|
|Corporate|**7,339**|7,065|
|Grants|**(53,847)**|140,428|
|Lotteries|**4,334**|5,382|
|National events|**17,906**|9,225|
|Regional events|**36,813**|36,263|
|Salesofmerchandise|**4,928**|4,686|
|Trusts|**30,905**|86,347|
||**58,106**|306,918|
|Investmentincome|||
|Deposit account interest|**908**|3,815|
|Current account interest|**538**|150|
|Dividendsonshares and other investments|**6,386**|6,095|
||**7,832**|10,060|
|Totalincomingresources|706,904|992,799|
|EXPENDITURE|||
|Raisingdonationsand legacies|||
|Merchandise|2,173|2,976|
|Events|**3,098**|3,357|
|Appeal mailings|996|349|
|Lottery|**3,232**|3647|
||**9,499**|10,329|
|Charitable activities|||
|Wages|**463,558**|509,640|
|Social security|**34,490**|36,906|
|Pensions|**30,463**|34,321|
|Medical research|**291,025**|267,677|
|Medical care|**1,529**||
|Travel and miscellaneous|**6,829**|5,600|
|Carried forward|**827,894**|854,144|



## 

## 

|2022<br>£<br>Charitableactivities<br>Brought forward<br>**827,894**<br>**MyNews**&member communications<br>**4,098**<br>Meetings and conferences<br>**1,055**<br>**833,047**<br>Supportcosts<br>Management<br>Rentalofpremises<br>**23,755**<br>Utilities and insurance<br>**18,177**<br>Office equipment<br>**3,845**<br>Printing, postage and stationery<br>**9,977**<br>Photocopiercosts<br>**1,299**<br>Support website<br>**23,933**<br>ITsupport&software<br>**47,084**<br>HRcosts<br>**10,356**<br>General expenses<br>**6,825**<br>Bank charges<br>**1,497**<br>Amortisationofintangible fixed assets<br>**15,525**<br>Depreciationoftangible fixed assets<br>**3,076**<br>**165,349**<br>Governancecosts<br>Trustees' expenses<br>**233**<br>Auditors' remuneration<br>**7,268**<br>Legal and professional fees<br>**6,757**<br>**14,258**<br>Total resources expended<br>**1,022,153**<br>Netexpenditurebeforegainsandlosses<br>**(315,249)**<br>Realisedrecognisedgainsandlosses<br>Realised gains/(losses) on fixedasset<br>investments<br>**18,493**<br>Netexpenditure<br>**(296,756)**|2021<br>£<br>854,144<br>7,158<br>1,427|
|---|---|
||862,729<br>23,760<br>17,255<br>2,315<br>11,680<br>1,009<br>30,461<br>38,773<br>5,044<br>1,131<br>1,573<br>25,363<br>6,280<br>164,644<br>7,941<br>6,774<br>14,715<br>1,052,41 7<br>(59,618)<br>35,783<br>(23,835)|



